Unknown file type. Enclosure URL IS: - https://ksithub.com/Uploadfiles/RTSLCoverageInitiationReportJune222020.pdf
Summary: Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) manufactures and markets FDA-listed pressurized metered dose inhalers (pMDIs) that enable users to conveniently and safely self-administer CBD. RTSL's MDIs deliver a 98% bioavailable dose of CBD each & every time and could very well replace vape pens, tanks and mods and have a major impact on a $9 Billion market.
